Gross Margin
6.06%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 9.69%.Updated Sep 21, 2026Profit Margin
-2.26%vs Specialty Chemicals peers Updated Sep 21, 2026Operating Margin
-2.28%vs Specialty Chemicals peers Updated Sep 21, 2026Return on Assets (TTM)
-0.77%vs Specialty Chemicals peers Updated Sep 21, 2026Return on Equity (TTM)
-2.41%vs Specialty Chemicals peers Updated Sep 21, 2026Revenue (TTM)
661.27MCNY98.67M · vs all stocks (USD) Updated Sep 21, 2026Revenue per Share (TTM)
2.20CNYUpdated Sep 21, 2026Quarterly Revenue Growth
291.80%vs Specialty Chemicals peers Updated Sep 21, 2026Gross Profit (TTM)
64.08MCNY9.56M · vs all stocks (USD) Updated Sep 21, 2026EBITDA (TTM)
23.18MCNY3.46M · vs all stocks (USD) Updated Sep 21, 2026Net Income (TTM)
-14.95MCNY-2.23M · vs all stocks (USD) Updated Sep 21, 2026Quarterly Earnings Growth (YoY)
201.74%vs Specialty Chemicals peers Updated Sep 21, 2026Operating Cash Flow (TTM)
-44.50MCNY-6.64M · vs all stocks (USD) Updated Sep 21, 2026Levered Free Cash Flow (TTM)
-38.73MCNY-5.78M · vs all stocks (USD) Updated Sep 21, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Sep 21, 2026Minority Interest (Equity)
4.19MCNYFY2025 · Dec 31, 2025Revenue
377.62MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
323.88MCNYFY2025 · Dec 31, 2025Gross Profit
53.75MCNYFY2025 · Dec 31, 2025Operating Income
-19.99MCNY-2.98M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-11.61MCNYFY2025 · Dec 31, 2025Income Tax Expense
15.14MCNYFY2025 · Dec 31, 2025Net Income
-26.75MCNYFY2025 · Dec 31, 2025EBIT
-8.13MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
23.18MCNYFY2025 · Dec 31, 2025Research & Development
8.23MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
24.47MCNYFY2025 · Dec 31, 2025Other Operating Expenses
6.04MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
676.61KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
3.48MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0861CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0861CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
300.34MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
300.34MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-26.75MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
894.35KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-48.75MCNYFY2025 · Dec 31, 2025Free Cash Flow
-60.33MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
94.70MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-26.75MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.61MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-6.86MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.74MCNYFY2025 · Dec 31, 2025Capital Expenditures
-11.58MCNYFY2025 · Dec 31, 2025Net Acquisitions
766.36KCNYFY2025 · Dec 31, 2025Purchase of Investments
-294.20MCNYFY2025 · Dec 31, 2025Sale of Investments
281.45MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-23.56MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
137.39MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-81.72MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-3.58MCNYFY2025 · Dec 31, 2025Other Financing Charges
-3.42MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
48.66MCNYFY2025 · Dec 31, 2025